Wako Nakajima

1.6k total citations
24 papers, 1.2k citations indexed

About

Wako Nakajima is a scholar working on Pediatrics, Perinatology and Child Health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Wako Nakajima has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Wako Nakajima's work include Neonatal and fetal brain pathology (14 papers), Neuroscience and Neuropharmacology Research (8 papers) and Anesthesia and Neurotoxicity Research (7 papers). Wako Nakajima is often cited by papers focused on Neonatal and fetal brain pathology (14 papers), Neuroscience and Neuropharmacology Research (8 papers) and Anesthesia and Neurotoxicity Research (7 papers). Wako Nakajima collaborates with scholars based in Japan, United States and Sweden. Wako Nakajima's co-authors include Michael V. Johnston, Akira Ishida, Akira Ishida, William H. Trescher, Alvin Zipursky, Goro Takada, Mary S. Lange, Mary E. Blue, Kathleen L. Gabrielson and Mary Ann Wilson and has published in prestigious journals such as Journal of Neuroscience, Brain Research and Experimental Neurology.

In The Last Decade

Wako Nakajima

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wako Nakajima Japan 15 718 368 231 212 206 24 1.2k
Małgorzata Puka‐Sundvall Sweden 15 826 1.2× 466 1.3× 213 0.9× 237 1.1× 207 1.0× 20 1.4k
Mary S. Lange United States 16 531 0.7× 313 0.9× 245 1.1× 176 0.8× 165 0.8× 22 1.2k
Leslie Schwendimann France 22 444 0.6× 325 0.9× 227 1.0× 251 1.2× 176 0.9× 40 1.2k
Eric Gilland Sweden 15 1.1k 1.5× 393 1.1× 248 1.1× 326 1.5× 254 1.2× 19 1.6k
Anna‐Lena Leverin Sweden 14 677 0.9× 466 1.3× 159 0.7× 373 1.8× 155 0.8× 16 1.4k
Eridan Rocha‐Ferreira United Kingdom 22 606 0.8× 308 0.8× 198 0.9× 296 1.4× 102 0.5× 39 1.2k
Elsa Bona Sweden 18 1.2k 1.7× 365 1.0× 272 1.2× 437 2.1× 224 1.1× 23 1.8k
Vincent Laudenbach France 17 339 0.5× 264 0.7× 231 1.0× 186 0.9× 284 1.4× 44 1.1k
Falin Xu China 18 1.0k 1.4× 440 1.2× 226 1.0× 532 2.5× 102 0.5× 64 1.8k
Haruo Hattori Japan 22 573 0.8× 415 1.1× 110 0.5× 107 0.5× 348 1.7× 50 1.5k

Countries citing papers authored by Wako Nakajima

Since Specialization
Citations

This map shows the geographic impact of Wako Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wako Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wako Nakajima more than expected).

Fields of papers citing papers by Wako Nakajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wako Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wako Nakajima. The network helps show where Wako Nakajima may publish in the future.

Co-authorship network of co-authors of Wako Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Wako Nakajima. A scholar is included among the top collaborators of Wako Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wako Nakajima. Wako Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakajima, Wako, et al.. (2007). Aseptic Meningitis Associated With Cephalosporins in an Infant With Trisomy 21. Journal of Child Neurology. 22(6). 780–782. 5 indexed citations
2.
Ishida, Akira, et al.. (2006). Intraventricular ascorbic acid administration decreases hypoxic–ischemic brain injury in newborn rats. Brain Research. 1095(1). 159–166. 22 indexed citations
3.
Nakajima, Wako, et al.. (2005). Calpain inhibitor MDL 28170 protects hypoxic–ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Research. 1037(1-2). 59–69. 56 indexed citations
4.
Nakajima, Wako, et al.. (2005). Prolonged hypothermia protects neonatal rat brain against hypoxic-ischemia by reducing both apoptosis and necrosis. Brain and Development. 27(7). 517–526. 67 indexed citations
5.
Nakajima, Wako, Akira Ishida, Masashi Hirayama, et al.. (2004). Good Outcome for Infant of Mother Treated With Chemotherapy for Ewing Sarcoma at 25 to 30 Weeks??? Gestation. Journal of Pediatric Hematology/Oncology. 26(5). 308–311. 17 indexed citations
6.
Nakajima, Wako, et al.. (2004). Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats. Developmental Brain Research. 151(1-2). 129–139. 52 indexed citations
7.
Johnston, Michael V., Wako Nakajima, & Henrik Hagberg. (2002). Mechanisms of Hypoxic Neurodegeneration in the Developing Brain. The Neuroscientist. 8(3). 212–220. 101 indexed citations
8.
Ishida, Akira, Shun Ishiwa, William H. Trescher, et al.. (2001). Delayed Increase in Neuronal Nitric Oxide Synthase Immunoreactivity in Thalamus and Other Brain Regions after Hypoxic–Ischemic Injury in Neonatal Rats. Experimental Neurology. 168(2). 323–333. 21 indexed citations
9.
Johnston, Michael V., William H. Trescher, Akira Ishida, Wako Nakajima, & Alvin Zipursky. (2001). The Developing Nervous System: A Series of Review Articles: Neurobiology of Hypoxic-Ischemic Injury in the Developing Brain. Pediatric Research. 49(6). 735–741. 336 indexed citations
10.
Nakajima, Wako, Akira Ishida, Mary S. Lange, et al.. (2000). Apoptosis Has a Prolonged Role in the Neurodegeneration after Hypoxic Ischemia in the Newborn Rat. Journal of Neuroscience. 20(21). 7994–8004. 354 indexed citations
11.
Johnston, Michael V., William H. Trescher, Akira Ishida, & Wako Nakajima. (2000). Novel treatments after experimental brain injury. Seminars in Neonatology. 5(1). 75–86. 50 indexed citations
12.
13.
Nakajima, Wako, Akira Ishida, & Goro Takada. (1999). Anoxic and hypoxic immature rat model for measurement of monoamine using in vivo microdialysis. Brain Research Protocols. 3(3). 252–256. 14 indexed citations
14.
15.
Nakajima, Wako, et al.. (1998). Effect of N-Methyl-D-Aspartate and Potassium on Striatal Monoamine Metabolism in Immature Rat: An In Vivo Microdialysis Study. Neurochemical Research. 23(9). 1159–1165. 3 indexed citations
16.
Ishida, Akira, Wako Nakajima, Hirokazu Arai, et al.. (1997). Cranial computed tomography scans of premature babies predict their eventual learning disabilities. Pediatric Neurology. 16(4). 319–322. 7 indexed citations
17.
Ishida, Akira, Yasushi Takahashi, Hirokazu Arai, et al.. (1997). A Case of Neonatal Choriocarcinoma. American Journal of Perinatology. 14(2). 79–82. 17 indexed citations
18.
Ishida, Akira, Wako Nakajima, & Goro Takada. (1997). Short-term fasting alters neonatal rat striatal dopamine levels and serotonin metabolism: an in vivo microdialysis study. Developmental Brain Research. 104(1-2). 131–136. 17 indexed citations
19.
Nakajima, Wako, Akira Ishida, & Goro Takada. (1996). Effect of anoxia on striatal monoamine metabolism in immature rat brain compared with that of hypoxia: an in vivo microdialysis study. Brain Research. 740(1-2). 316–322. 22 indexed citations
20.
Ishida, Akira, Yukio Sawaishi, Atsuko Goto, et al.. (1993). Two Siblings with Partial Trisomy 15 and Monosomy 21 Associated with Central Nervous System Anomalies.. The Tohoku Journal of Experimental Medicine. 171(4). 277–283. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Małgorzata Puka‐Sundvall Breakdown of academic impact, for papers by Mary S. Lange Breakdown of academic impact, for papers by Leslie Schwendimann Breakdown of academic impact, for papers by Eric Gilland Breakdown of academic impact, for papers by Anna‐Lena Leverin Breakdown of academic impact, for papers by Eridan Rocha‐Ferreira Breakdown of academic impact, for papers by Elsa Bona Breakdown of academic impact, for papers by Vincent Laudenbach Breakdown of academic impact, for papers by Falin Xu Breakdown of academic impact, for papers by Haruo Hattori
Rankless by CCL
2026